Information about risk, prevention, screening, symptoms, diagnosis, treatment, and support for all cancers Information about cancer treatment, including surgery, chemotherapy, radiation therapy, clinical trials, proton therapy, complementary medicine, and cutting edge technologies.
Ways for cancer patients and caregivers to cope with cancer, side effects, nutrition, general cancer support issues, grief/end of life issues, and shared survivor's experiences.
Frequently Asked Questions / Types of Cancer / Pediatric Cancers / Retinoblastoma
Last Modified: April 27, 2008
![]()
Dear OncoLink "Ask The Experts,"
I have two sons. They have two uncles, both of whom had bilateral retinoblastoma as infants. The uncles’ older brother (my boys’ father) did not ever develop it. He has never been tested. The uncles were born in the late ‘50s. My boys were born in the ‘70’s and had their retinas examined under general anesthesia periodically until they were two years old. My question is: can you determine a percentage of chance that my boys could have children that would have retinoblastoma?
![]()
Eric Shinohara, MD, Resident in the Department of Radiation Oncology at The University of Pennsylvania Medical Center, responds:
Given the available information, we can hazard a guess at the risk (making certain assumptions), but we cannot provide an exact percentage chance that your grandchildren will have retinoblastoma. It appears from your information above that two of three brothers had bilateral retinoblastoma, while the oldest brother, the father of your children, did not develop retinoblastoma. This suggests that one of the brothers’ parents carried a defective retinoblastoma gene. One possibility is that two of the brothers inherited the defective gene, and then unfortunately developed a second defect in the other copy of the retinoblastoma gene, thus resulting in the disease. In this scenario, the eldest brother did not inherit a copy of the gene, just by chance. Another possibility is that all three brothers inherited one defective gene, but the father of your children simply never had a second mutation and so he never manifested the disease. Yet a third and far less likely possibility is that - by complete chance - the two brothers with retinoblastoma both developed the sporadic form of the disease resulting in retinoblastoma, while the father of your children did not.
Based on these assumptions, the father of your children could have either: 1) inherited a single copy of the defective retinoblastoma gene (without ever manifesting signs of the disease from this single defect), or 2) be completely free of the mutation. Hence, it is impossible to know for certain whether your children are carriers of the defective retinoblastoma gene or not with the information we have at present.
Unfortunately, as you can see from the above discussion, it is impossible to determine the exact percentage risk. I would encourage you to contact a genetic counselor near you to discuss genetic testing with you and your family, and to see if further testing could help to determine the risk to your sons' children. Most genetic testing does require the testing of an affected individual, in this case one of the uncles, to identify the defective gene, if one is present. In some cases, tumor specimens that are stored can be used for testing, but the time that has passed since the cases were diagnosed makes this unlikely. To find a genetic counselor near you to discuss the options, you can use the search feature at the NCI site.
Quitting smoking after a cancer diagnosis has many benefits for the patient. Read more.
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Cladribine (2-CDA, Leustatin®)
Cyclophosphamide (Cytoxan®, Neosar®, Endoxan®)
Cyclosporine (Neoral®, Sandimmune®, Restasis®, Gengraf®)
Cytarabine (Cytosar-U®, Ara-C)
Irinotecan (Camptosar®, CPT-11)
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Men
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Women
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Busulfan (Myleran®, Busulfex®)
Intravesicular Mitomycin (Mutamycin®, Mitomycin-C, given into the bladder)
Mechlorethamine (Mustargen®, Nitrogen Mustard)
mechlorethamine, mustine, Mustargen®
Megestrol (Megace®, Megace-ES®)
Mercaptopurine (Purinethol®, 6-MP)
Methotrexate (Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX)
Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX
Mitomycin (Mutamycin®, Mitomycin-C)
Morphine Sulfate (Given by IV)
Morphine Sulfate (MS Contin®, Avinza®, Kadian®, Oramorph SR®)
MS Contin®, Avinza®, Kadian®, Oramorph SR®
Mutamycin®, Mitomycin-C, given into the bladder
Nitrogen mustard (mechlorethamine, mustine, Mustargen®)
Bendamustine Hydrochloride (Treanda®)
Bexarotene (Targretin®), Oral Formulation
Bexarotene Gel (Targretin® Gel Formulation)
Etoposide (Toposar®, VePesid®, Etopophos®,VP-16)
Thioguanine (6-TG, Thioguanine Tabloid®)
Toposar®, VePesid®, Etopophos®,VP-16
Trelstar LA® and Trelstar Depot®
Tretinoin (Vesanoid®, All-Trans-Retinoic Acid, ATRA)
Triptorelin (Trelstar LA® and Trelstar Depot®)


